Spinal Tech

RTI Biologics, a provider of orthopedic and other biologic implants, reported quarterly revenues of $45.2 million, a 4 percent increase over the second quarter of 2011.

ArthroCare's second quarter revenue reached $97.1 million, indicated a 0.5 percent increase over the same quarter last year.

Globus Medical, a spinal implant manufacturer, announced the pricing of its initial public offering of more than 8 million shares of Class A common stock at a price of $12 per share.

The Japanese market for orthopedic soft tissue repair and sports medicine exceeded $1 billion in 2011, according to the latest analysis from Research and Markets.

The global spinal device and biologics market is expected to grow at a compound annual growth rate of 6.9 percent until 2015, according to the latest analysis by Reporterlink.

DePuy Synthes Spine has received 510(k) clearance from the FDA for use of its EXPEDIUM, VIPER and VIPER2 Spine Systems on patients with adolescent idiopathic scoliosis.

Symmetry Medical's second quarter revenue reached $102.3 million, representing an 8 percent increase over the same quarter last year.

TranS1 completed its first head-to-head retrospective study comparing its proprietary AxiaLIF pre-sacral interbody fusion procedure to anterior lumbar interbody fusion.

Conventus Orthopaedics has completed enrollment of an international multi-center clinical study of the Conventus DRS Implant with 60 patients from six institutions throughout Germany and Switzerland.

MAKO Surgical has reached second quarter revenue of $23.7 million, a 27 percent increase over the same period in 2011.